Bio-Techne (TECH) Dividend Yield & History

TECH$72.73—
BiotechnologyLarge CapHigh Quality
Compare
Market cap$11.44BEnterprise value$11.45BRevenue (TTM)$1.22BMarket positionTop 25%

Score

52
Neutral
Value
29
Quality
78
Growth
48
$72.73Price
$11.44BMarket cap
62.89P/E
34.35Forward P/E
0.44%Dividend yield

Yield is based on dividends paid in the past 12 months. 2026 isn't counted in streaks until the year ends.

Bio-Techne Corporation paid $0.32 a share over the past year. At $72.73 that is a 0.44% yield.

Bio-Techne raised its yearly dividend in 0 of the last 5 years.

On 6 November 2014 Bio-Techne raised its quarterly dividend from $0.0775 to $0.0800, up 3.2%.

The dividend was 27% of Bio-Techne earnings last year.

Bio-Techne pays quarterly, roughly every three months.

The next ex-dividend date for Bio-Techne is 13 November 2026, and the pay date is 23 November 2026.

Over five years the Bio-Techne dividend grew 0% a year.

Our records cover 73 payments from 2008 to 2026.

At today's yield, $10,000 invested would receive about $44 a year in dividends before tax, if payments stay the same. Dividends can be cut.

Learn: How to read a dividend

Full TECH quote · Forecast · Academy

Questions

When did TECH last raise the dividend?

$0.0800 replaced $0.0775 on 6 November 2014.

How often does TECH pay a dividend?

Bio-Techne pays four times a year.

How many years has TECH raised the dividend?

In 0 of the last 5 years. 2025 totalled $0.32 a share.

What is the TECH dividend yield?

Bio-Techne yields 0.44%.

How long after the TECH ex-dividend date is the cash paid?

10 days.

Bio-Techne (TECH) Dividend Yield & History

TECH price $72.73 —

Ticker
TECH
Price
$72.73
Change
—
Market cap
$11.44B
P/E
62.89
Forward P/E
34.35
Dividend yield
0.44%
Beta
1.27
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
52
Value
29
Quality
78
Growth
48

Stocklytics score rationale: value 29, quality 78, growth 48.

AI Score 70. Bio-Techne Corporation has a strong gross profit margin of approximately 65.8% and a solid net profit margin of about 14.97%, indicating good profitability. However, its high price-to-earnings ratio of around 62.1 suggests that the stock may be overvalued, despite a reasonable growth outlook reflected in its price-to-earnings growth ratio of 0.40

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener